Difference between revisions of "Wang Y, et al. Int. J. Mol. Med. (2014) cited as Ref 387 in DOI: 10.1038/s41392-020-0110-5 (Q9650)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2014, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Page(s) (P105): 262-268, #quickstatements; #temporary_batch_1590074839150) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Property / Published In Name String | |||
| + | Int. J. Mol. Med. | ||
| Property / Published In Name String: Int. J. Mol. Med. / rank | |||
| + | Normal rank | ||
| Property / Volume | |||
| + | 34 | ||
| Property / Volume: 34 / rank | |||
| + | Normal rank | ||
| Property / title | |||
| + | The combinatory effects of PPAR-gamma agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells (English) | ||
| Property / title: The combinatory effects of PPAR-gamma agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 262-268 | ||
| Property / Page(s): 262-268 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:39, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Wang Y, et al. Int. J. Mol. Med. (2014) cited as Ref 387 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Wang Y
0 references
2014
0 references
Int. J. Mol. Med.
0 references
34
0 references
The combinatory effects of PPAR-gamma agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells (English)
0 references
262-268
0 references
